Results for tag: "Kidney Fibrosis Drug"

The Kidney Fibrosis Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. These drugs are used to treat a variety of conditions, including kidney fibrosis, a condition in which the kidneys become scarred and unable to filter waste from the body. Treatment options for kidney fibrosis include medications, lifestyle changes, and surgery. Common medications used to treat kidney fibrosis include angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and diuretics. These drugs work by reducing inflammation and preventing further damage to the kidneys. The Kidney Fibrosis Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AstraZeneca, Pfizer, Merck, Novartis, and Sanofi. These companies offer a range of treatments, from generic drugs to more specialized treatments. Additionally, many of these companies are actively researching new treatments for kidney fibrosis, with the aim of providing more effective and affordable treatments. Show Less Read more